QuidelOrtho Price to Book Ratio 2012-2026 | QDEL
Historical price to book ratio values for QuidelOrtho (QDEL) over the last 10 years. The current price to book ratio for QuidelOrtho as of September 15, 2026 is 0.43.
| QuidelOrtho Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-15 | 10.63 | 0.41 | |
| 2026-06-30 | 17.52 | $25.99 | 0.67 |
| 2026-03-31 | 16.43 | $27.19 | 0.60 |
| 2025-12-31 | 28.56 | $28.28 | 1.01 |
| 2025-09-30 | 29.45 | $29.99 | 0.98 |
| 2025-06-30 | 28.82 | $41.25 | 0.70 |
| 2025-03-31 | 34.97 | $44.40 | 0.79 |
| 2024-12-31 | 44.55 | $44.35 | 1.00 |
| 2024-09-30 | 45.60 | $47.42 | 0.96 |
| 2024-06-30 | 33.22 | $47.30 | 0.70 |
| 2024-03-31 | 47.94 | $49.52 | 0.97 |
| 2023-12-31 | 73.70 | $75.05 | 0.98 |
| 2023-09-30 | 73.04 | $74.35 | 0.98 |
| 2023-06-30 | 82.86 | $74.89 | 1.11 |
| 2023-03-31 | 89.09 | $75.02 | 1.19 |
| 2022-12-31 | 85.67 | $74.32 | 1.15 |
| 2022-09-30 | 71.48 | $72.66 | 0.98 |
| 2022-06-30 | 97.18 | $73.43 | 1.32 |
| 2022-03-31 | 112.46 | $57.71 | 1.95 |
| 2021-12-31 | 134.99 | $46.27 | 2.92 |
| 2021-09-30 | 141.15 | $39.21 | 3.60 |
| 2021-06-30 | 128.12 | $33.89 | 3.78 |
| 2021-03-31 | 127.93 | $35.02 | 3.65 |
| 2020-12-31 | 179.65 | $31.51 | 5.70 |
| 2020-09-30 | 219.38 | $20.20 | 10.86 |
| 2020-06-30 | 223.74 | $14.58 | 15.34 |
| 2020-03-31 | 97.81 | $14.41 | 6.79 |
| 2019-12-31 | 75.03 | $13.37 | 5.61 |
| 2019-09-30 | 61.35 | $12.83 | 4.78 |
| 2019-06-30 | 59.32 | $12.31 | 4.82 |
| 2019-03-31 | 65.47 | $11.57 | 5.66 |
| 2018-12-31 | 48.82 | $10.81 | 4.52 |
| 2018-09-30 | 65.17 | $9.88 | 6.60 |
| 2018-06-30 | 66.50 | $9.46 | 7.03 |
| 2018-03-31 | 51.81 | $8.84 | 5.86 |
| 2017-12-31 | 43.35 | $6.58 | 6.59 |
| 2017-09-30 | 43.86 | $6.44 | 6.81 |
| 2017-06-30 | 27.14 | $6.36 | 4.27 |
| 2017-03-31 | 22.64 | $6.63 | 3.41 |
| 2016-12-31 | 21.42 | $6.10 | 3.51 |
| 2016-09-30 | 22.09 | $6.03 | 3.67 |
| 2016-06-30 | 17.86 | $5.96 | 3.00 |
| 2016-03-31 | 17.26 | $6.14 | 2.81 |
| 2015-12-31 | 21.20 | $6.56 | 3.23 |
| 2015-09-30 | 18.88 | $6.57 | 2.88 |
| 2015-06-30 | 22.95 | $6.79 | 3.38 |
| 2015-03-31 | 26.98 | $7.29 | 3.70 |
| 2014-12-31 | 28.92 | $7.12 | 4.06 |
| 2014-09-30 | 26.87 | $6.32 | 4.25 |
| 2014-06-30 | 22.11 | $6.41 | 3.45 |
| 2014-03-31 | 27.30 | $6.58 | 4.15 |
| 2013-12-31 | 30.89 | $6.57 | 4.70 |
| 2013-09-30 | 28.40 | $6.41 | 4.43 |
| 2013-06-30 | 25.53 | $6.48 | 3.94 |
| 2013-03-31 | 23.75 | $6.47 | 3.67 |
| 2012-12-31 | 18.67 | $5.97 | 3.13 |
| 2012-09-30 | 18.93 | $5.61 | 3.38 |
| 2012-06-30 | 15.68 | $5.55 | 2.83 |
| 2012-03-31 | 18.37 | $5.59 | 3.28 |
| 2011-12-31 | 15.13 | $5.57 | 2.72 |
| 2011-09-30 | 16.37 | $5.49 | 2.98 |
| 2011-06-30 | 15.15 | $5.47 | 2.77 |
| 2011-03-31 | 11.96 | $5.53 | 2.16 |
| 2010-12-31 | 14.45 | $3.95 | 3.66 |
| 2010-09-30 | 10.99 | $3.90 | 2.82 |
| 2010-06-30 | 12.69 | $4.06 | 3.12 |
| 2010-03-31 | 14.54 | $4.20 | 3.46 |
| 2009-12-31 | 13.78 | $4.36 | 3.16 |
| 2009-09-30 | 16.23 | $3.92 | 4.14 |
| 2009-06-30 | 14.56 | $3.34 | 4.35 |
| 2009-03-31 | 9.22 | $3.46 | 2.66 |
| 2008-12-31 | 13.07 | $3.74 | 3.50 |
| 2008-09-30 | 16.41 | $3.84 | 4.28 |
| 2008-06-30 | 16.54 | $3.45 | 4.79 |
| 2008-03-31 | 16.06 | $3.44 | 4.67 |
| 2007-12-31 | 19.47 | $3.29 | 5.91 |
| 2007-09-30 | 19.56 | $2.99 | 6.54 |
| 2007-06-30 | 17.56 | $2.86 | 6.13 |
| 2007-03-31 | 12.00 | $2.97 | 4.05 |
| 2006-12-31 | 13.62 | $3.08 | 4.42 |
| 2006-09-30 | 14.12 | $2.52 | 5.61 |
| 2006-06-30 | 9.50 | $2.64 | 3.60 |
| 2006-03-31 | 12.87 | $2.74 | 4.69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.763B | $2.730B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |